Lieven D. Declercq
Leuven, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Correction to Discovery of N-(4-[18F]Fluoro-5-methylpyridin-2-yl)isoquinolin-6-amine (JNJ-64326067), a New Promising Tau Positron Emission Tomography Imaging Tracer.
Journal: Journal of medicinal chemistry
Published: February 19, 2020
TSPO Versus P2X7 as a Target for Neuroinflammation: An In Vitro and In Vivo Study.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: June 03, 2019
Discovery of N-(4-[18F]Fluoro-5-methylpyridin-2-yl)isoquinolin-6-amine (JNJ-64326067), a New Promising Tau Positron Emission Tomography Imaging Tracer.
Journal: Journal of medicinal chemistry
Published: February 28, 2019
Distinct [18F]THK5351 binding patterns in primary progressive aphasia variants.
Journal: European journal of nuclear medicine and molecular imaging
Published: April 12, 2018
Increased Expression of Translocator Protein (TSPO) Marks Pro-inflammatory Microglia but Does Not Predict Neurodegeneration.
Journal: Molecular imaging and biology
Published: July 12, 2017
Synthesis and preclinical evaluation of [11C]MA-PB-1 for in vivo imaging of brain monoacylglycerol lipase (MAGL).
Journal: European journal of medicinal chemistry
Published: February 08, 2017
Preclinical Evaluation of 18F-JNJ64349311, a Novel PET Tracer for Tau Imaging.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: November 03, 2016
Drug Development in Alzheimer's Disease: The Contribution of PET and SPECT.
Journal: Frontiers in pharmacology
Published: February 05, 2016
Comparison of New Tau PET-Tracer Candidates With [18F]T808 and [18F]T807.
Journal: Molecular imaging
Published: September 17, 2015
Retention of [(18)F]fluoride on reversed phase HPLC columns.
Journal: Journal of pharmaceutical and biomedical analysis
Published: January 30, 2015
Showing 1-10 of 10
Last Updated: 09/26/2026